Seeing Is Believing
with an average price target of $226433.38. This is a potential upside of $226426.67 (3374466.02%) from yesterday's end of day stock price of $6.71.
Aptevo Therapeutics's activity chart (see below) currently has 25 price targets and 23 ratings on display.
Analysts average stock forecasts to be materialized ratio is 13.33% with an average time for these price targets to be met of 265.33 days.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 23-Sep-2024. First documented stock forecast 05-Oct-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Nov-2020
$1172160
1 years 4 months 23 days ago
(23-Sep-2024)
0/3 (0%)
$172160 (17.22%)
Buy Since 28-Feb-2020
$423280
$423273.28 (6308096.50%)
$651200
3 years 6 months 3 days ago
(12-Aug-2022)
4/10 (40%)
$-576720 (-57.67%)
796
Buy Since 05-Nov-2018
$2083840
$2083833.25 (31055638.00%)
5 years 3 months 6 days ago
(09-Nov-2020)
0/1 (0%)
$1083840 (108.38%)
What is APVO (Aptevo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?
Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?
Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?
Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?